Research by Zhu et al. found that the expression of TP73-AS1 was significantly elevated in tumor tissues of non-small cell lung cancer (NSCLC) patients compared to normal tissues, and its high expression was closely associated with poorer OS in patients [12]. This evidence concerns the gene TP73 and non-small cell lung carcinoma.